Less likelihood of complications of diabetes, heart problems, and nerve damage
Over 200 clinical trials have confirmed that GLP-1 receptor activation leads to measurable reductions in food intake and body weight
20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
After 12 weeks, the researchers noted the following weight changes in the two groups: [table id=356 /] The following blood work changes were also found in the two groups: [table id=357 /] For the researchers, 12 weeks of carnitine administration in women with polycystic ovary syndrome resulted in reductions in weight, body mass index, weight circumference, and hip circumference, and beneficial effects on blood sugar control though they admit that Further long-term studies with higher doses of carnitine are needed to examine the effect of carnitine supplementation on markers of insulin resistance, lipid profiles and hormonal outcomes in polycystic ovary syndrome patients. * HOMA RI is used as a screening test for glucose intolerance
13 Patients can be reassured that the greater the inflammatory reaction, the more effective the treatment is likely to be, but pain can be substantial and treatment is often discontinued early
Mean relative liver fat reduction was greater than 80% with retatrutide 8 mg and 12 mg, and 80% or more of participants on retatrutide 8 mg and 12 mg had a 70% or more relative reduction in liver fat